Bionaut Labs

Bionaut Labs
Remote-controlled micro-robots for precise treatment of central nervous system disorders.
About
What does Bionaut Labs do?
Bionaut Labs is developing Bionauts™, a novel class of remote-controlled micro-robots designed to revolutionize the treatment of central nervous system (CNS) disorders. These micro-robots offer the potential for safe and precise delivery of therapeutics deep within the brain, targeting structures that are currently difficult to access with conventional methods.
What is Bionaut Labs's revenue?
StartupHub estimates Bionaut Labs's annual revenue at $5.0M (range $3.1M to $7.4M, 66% confidence), based on comparable companies in the sector.
What is Bionaut Labs's valuation?
StartupHub estimates Bionaut Labs's effective valuation at $303.4M (range $180.0M to $432.0M, 14% confidence), based on comparable companies in the sector.
How much funding has Bionaut Labs raised?
Bionaut Labs has raised a total of $72M in funding. The most recent round on record is Series B.
Where is Bionaut Labs headquartered?
Bionaut Labs is headquartered in Tel Aviv, Israel.
When was Bionaut Labs founded?
Bionaut Labs was founded in 2016.
What industry does Bionaut Labs operate in?
Bionaut Labs operates in Healthcare, Diagnostics, Drug Delivery, Robotics, Surgery, MedTech.
How many employees does Bionaut Labs have?
Bionaut Labs has approximately 26 people on record.
No comments yet. Be the first to share your take.